only lost 5 pounds in a month on semaglutide Woman shares journey of weight loss and gain after using Your First 3 Months on

Caueto J, Cardeoso E, Garca JL, Santos-Briz, Castellanos-Martn A, Fernndez-Lpez E, et al

On average, tirzepatide has been shown in research to lead to a greater amount of weight loss : People with obesity in clinical trials for tirzepatide lost, on average, 20% of their body weight at week 72 (and about 7 inches off their waistlines), compared with about 14% of their body weight (and about 5 inches off their waistlines) with semaglutide

UK Evidence and Guidance Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with comorbidities

It restores balance and promotes a clearer, more even complexion